COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Remapping Atrial Fibrillation Treatment

 

February 14, 2022  |  

A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health. vMap is a non-invasive, computational mapping system that produces a three-dimensional, interactive map of arrhythmia hotspots anywhere in the heart, including all four chambers of the organ, the septal wall and the outflow tracts. The system, which maps in a matter of minutes, requires only the data from a standard 12-lead electrocardiogram (ECG) to work.

V-Map

vMap is a non-invasive arrhythmia-mapping system designed to identify arrhythmia hotspots anywhere in the heart in minutes using only a 12-lead electrocardiogram. Photo credit: Vektor Medical

AF is an irregular and often rapid heart rhythm that can cause stroke and heart failure. It affects more than six million Americans, resulting in more than 41,000 deaths annually. The standard of care for treating the condition is ablation, in which small, steerable catheters are inserted into the heart to burn or freeze specific areas responsible for the electrical signals causing the abnormal heartbeat.

But how are those specific areas located? Traditional arrhythmia-mapping techniques are labor-and time-intensive, and physicians are only able to achieve complete success in a limited number of ablation procedures due to the lack of information about arrhythmia source locations. AF recurs following catheter ablation in 20 to 40 percent of cases, according to the Journal of Atrial Fibrillation.

Existing invasive mapping has limitations in speed, efficacy and safety, and existing non-invasive mapping requires additional steps, such as magnetic resonance imaging and computerized tomography, and cannot map the entire heart organ. To shorten procedure times and improve ablation success, electrophysiologists need to be able to visualize arrhythmia hotspots in the heart quickly and accurately.

“My team and I experienced first-hand the limitations of the current standard of care for understanding and treating arrhythmias.” said David Krummen, MD, cardiac electrophysiologist at UC San Diego Health and professor of medicine at University of California San Diego School of Medicine, who co-invented vMap and serves as clinical advisor to Vektor Medical, its manufacturer.

David Krummen

David Krummen, MD, cardiac electrophysiologist at UC San Diego Health and professor of medicine at UC San Diego School of Medicine, is a co-inventor of vMap.

“We designed vMap to improve ablation outcomes by rapidly providing arrhythmia source information to the physician. We want this technology to increase first-pass ablation success, decrease procedural risk, and improve the care of patients with heart rhythm abnormalities.”

vMap — which received Food and Drug Administration clearance in November 2021 — converts ECG data into 2D and 3D arrhythmia source maps using data leveraged from millions of arrhythmia simulations performed by technology resources, including the UC San Diego’s San Diego Supercomputer Center. The results from vMap’s first clinical study will be published later this year.

vMap is now available to assist physicians and electrophysiologists at UC San Diego Health with arrhythmia analysis and mapping. To learn more about vMap, please speak to your physician.

Disclosure: David Krummen, MD, cardiac electrophysiologist at UC San Diego Health and professor of medicine at UC San Diego School of Medicine, co-invented vMap and serves as clinical advisor to its manufacturer, Vektor Medical, which he co-founded.


Care at UC San Diego Health

Cardiac Arrhythmia



Media Contact

Corey Levitan
858-249-0456
colevitan@health.ucsd.edu

Share This Article


Related News

5/6/2022
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formati ...
3/9/2022
The Adult Congenital Heart Disease program at UC San Diego Health has received accreditation from the Adult Congenital Heart Association (ACHA) as a comprehensive care center, a first for San Diego.
1/3/2022
Computer simulations from UC San Diego School of Medicine reveal the action mechanism and substrate specificity of an important blood enzyme. These findings open the door for new therapeutics against ...
12/9/2021
How two of UC San Diego Health’s record-breaking 81 heart transplant recipients in 2021 forged a unique bond of mutual support.



Follow Us